Overview

Effectiveness of Stellate Ganglion Block in Individuals With Parkinson's Disease

Status:
NOT_YET_RECRUITING
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The goal of this or clinical trial is to explore efficacy of stellate ganglion block on dysphagia and activities of daily living in patients with Parkinson's disease. The main question it aims to answer are: • Can stellate ganglion block improve the dysphagia and activities of daily living in patients with Parkinson's disease. Participants will be divided into the the control group and observation group evenly. All the patients were provided with routine therapy, while the patients in the observation group were given stellate ganglion block. The swallowing function, and activities of daily living of the two groups of patients before and after treatment were evaluated.
Phase:
NA
Details
Lead Sponsor:
Muhammad
Treatments:
Injections
Lidocaine